Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|October 26, 2020
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphomaThomas D Rodgers, AnnaLynn M Williams, Andrea Baran, et al.
Cancer Medicine|October 5, 2016
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effectiveRobin M Reid, Andrea Baran, Jonathan W Friedberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2018
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center ExperienceAnnaLynn M Williams, Andrea M Baran, Carla Casulo, et al.
Cancers|January 21, 2023
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 StudyJennifer A Woyach, Paul M Barr, Thomas J Kipps, et al.
Blood|April 27, 2018
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphomaTycel J Phillips, Andres Forero-Torres, Taimur Sher, et al.
British Journal of Haematology|August 7, 2009
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaPaul M Barr, Pingfu Fu, Hillard M Lazarus, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Leukemia & Lymphoma|July 12, 2017
Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapiesAnnaLynn M Williams, Andrea M Baran, Philip J Meacham, et al.
American Journal of Hematology|June 19, 2009
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplantPaul M Barr, Hillard M Lazarus, Brenda W Cooper, et al.
Leukemia & Lymphoma|March 17, 2020
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)Philip J Meacham, AnnaLynn M Williams, Myla Strawderman, et al.
Pageof 11